The Eft of Dual Inhibitor, Sk&F 86002, On Helper T Cell Functions
- 1 January 1990
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 12 (1) , 105-121
- https://doi.org/10.3109/08923979009006464
Abstract
SK&F 86002, a mixed cyclooxygenase-lipoxygenase inhibitor, was examined for its effects on helper T cell functions. The drug was found to inhibit concanavalin A-induced mitogenesis of splenic T cells (IC50 = 13 mμm), the mixed lymphocyte response (IC50 = 16 mμM), and proliferation of antigen specific T cells (cloned line, IC50 = 11 mμM; uncloned line, IC50 = 13 mμM). In contrast, another mixed cycloxygenase-lipoxygenase inhibitor, BW775c, did not have such effects at non-cytotoxic levels. These T cell functions are believed to be dependent on the effects of elaborated IL-1. SK&F 86002 has been shown to inhibit the production of mature IL-1 (IC50 = 1 mμM), possibly accounting for the anti-inflammatory effects of the drug in rheumatoid arthritis models. In an in vivo model of contact sensitivity, SK&F 86002 was able to inhibir mouse footpad swelling, demonstrating additional anti-inflammatory activity. As an inhibitor of IL-1 synthesis or release, SK&F 86002 may be useful for the treatment of T cell-dependent inflammation.This publication has 24 references indexed in Scilit:
- Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002International Journal of Immunopharmacology, 1988
- Arachidonic acid-induced inflammation: Inhibition by dual inhibitor of arachidonic acid metabolism, SK&F 86002Inflammation, 1987
- The Study and Manipulation of Experimental Autoimmune Disease Using T Lymphocyte LinesJournal of Investigative Dermatology, 1985
- Leukotriene B 4 Produces Hyperalgesia That Is Dependent on Polymorphonuclear LeukocytesScience, 1984
- Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteinsEuropean Journal of Pharmacology, 1984
- T lymphocyte lines induce autoimmune encephalomyelitis, delayed hypersensitivity and bystander encephalitis or arthritisEuropean Journal of Immunology, 1984
- Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4British Journal of Pharmacology, 1983
- The release of leukotriene B4 during experimental inflammationBiochemical Pharmacology, 1983
- Leukotriene B4General Pharmacology: The Vascular System, 1981
- Species difference in increased vascular permeability by synthetic leukotriene C4 and D4Prostaglandins, 1981